Oncofertility is a medical field that bridges oncology and reproductive endocrinology. Oncofertility aims to maximize the chances that cancer patients and survivors can have a family despite their illness.
Cancer treatments—including chemotherapy, radiation, and surgery—may impair or destroy a person's ability to have children later in life. For women, these therapies can cause ovarian damage, early menopause, or other reproductive problems. For men, treatments can cause damage to the testes, which interferes with sperm production.
As cancer treatments improve and more patients survive, fertility preservation options for women, men, and children become increasingly important. Fortunately, there are many treatment options available. Cancer patients or survivors can consult with our reproductive endocrinologists as early as possible following diagnosis, particularly prior to chemotherapy or pelvic radiation.Fertility preservation treatment options include: